CG Oncology, Inc.'s promising bladder cancer therapy has strong clinical results, competitive CR rates, and a $69 target ...

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.

Explore key aspects of progressive genetic hearing loss, from causes to future hope, in this in-depth look at a silent challenge.

“Diagnosing Gaucher disease typically involves a combination of clinical evaluation, family history, and laboratory tests. A ...

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

A dangerous bird flu, in other words, was suddenly circulating in mammals — mammals with which people have ongoing, extensive ...

The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...

Atsena Therapeutics has raised $150 million in a round led by Bain Capital, a private investment firm based in Boston. The ...

A key pressure-sensing protein involved in gut motility could be utilized for precision-targeted treatments for intestinal ...